✦ LIBER ✦

Chemoprevention of colorectal cancer in inflammatory bowel disease

✍ Scribed by Venkataraman Subramanian; Richard F. Logan

Book ID: 116325809
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 497 KB
Volume: 25
Category: Article
ISSN: 1521-6918
DOI: 10.1016/j.bpg.2011.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprevention of colorectal cancer in

Chemoprevention of colorectal cancer in inflammatory bowel disease

✍ J.R. Butterworth 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Colorectal cancer in inflammatory bowel

Colorectal cancer in inflammatory bowel disease

✍ Raoul Mayer; W. Douglas Wong; David A. Rothenberger; Stanley M. Goldberg; Robert 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 603 KB

Colorectal cancer in inflammatory bowel

Colorectal cancer in inflammatory bowel disease

✍ Rupert W L Leong; Jenn H Koo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Interval Colorectal Cancers in Inflammat

Interval Colorectal Cancers in Inflammatory Bowel Disease

✍ Sanduleanu, Silvia; Rutter, Matthew D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 942 KB

Colorectal Cancer in Patients with Infla

Colorectal Cancer in Patients with Inflammatory Bowel Disease

✍ Parsia A. Vagefi; Walter E. Longo 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 222 KB

Chemoprophylaxis of colorectal cancer in

Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts

✍ Jonathan S. Levine; Robert Burakoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa